AstraZeneca’s Covid-19 Vaccine Trial Paused after Unexplained Illness

FILE PHOTO: A general view of AstraZeneca's Sydney headquarters, in Sydney, Australia, August 19, 2020. AAP Image/Dan Himbrechts via REUTERS
FILE PHOTO: A general view of AstraZeneca's Sydney headquarters, in Sydney, Australia, August 19, 2020. AAP Image/Dan Himbrechts via REUTERS
TT
20

AstraZeneca’s Covid-19 Vaccine Trial Paused after Unexplained Illness

FILE PHOTO: A general view of AstraZeneca's Sydney headquarters, in Sydney, Australia, August 19, 2020. AAP Image/Dan Himbrechts via REUTERS
FILE PHOTO: A general view of AstraZeneca's Sydney headquarters, in Sydney, Australia, August 19, 2020. AAP Image/Dan Himbrechts via REUTERS

Clinical trials on one of the most advanced experimental Covid-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, were "paused" Tuesday after a volunteer developed an unexplained illness.

With billions of people around the world still suffering with the fallout of the pandemic and the global death toll nearing 900,000, a worldwide race for a vaccine is underway, with nine companies already in late-stage Phase 3 trials.

Worldwide infections to date now stand at more than 27 million, and more than 890,000 people have died from the disease.

Russia has already approved a vaccine, and research published in The Lancet medical journal last week said patients involved in early tests developed antibodies with "no serious adverse events", although scientists cautioned the trials were too small.

A spokesperson for the AstraZeneca vaccine said in a statement "we voluntarily paused vaccination to allow review of safety data by an independent committee".

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials."

The company said that in large-scale trials, illnesses will sometimes happen by chance, but must be reviewed independently.

AstraZeneca did not offer further details, but David Lo, a professor of biomedical sciences at the University of California, Riverside, told AFP the pause may not necessarily be a setback.

"Probably right now it's just being cautious -- it's a pause, it's not the same thing as saying, 'We can't move forward'," said Lo.

"In some ways I'm quite relieved, it means they're really paying attention."

The volunteer may have experienced an adverse reaction already seen in earlier patients such as fever and soreness, but in a more severe form, Lo added.

Britain's Health Secretary Matt Hancock also said that the pause was a challenge but would not necessarily set back efforts to develop a vaccine.

"It is obviously a challenge to this particular vaccine trial," Hancock said on Sky News when asked about the pause in the trial. "It's not actually the first time this has happened to the Oxford vaccine."

Asked whether it would set back the vaccine development process, he said: "Not necessarily, it depends on what they find when they do the investigation."

The trial's suspension triggered a 2% fall in AstraZeneca's shares in London and a 12% drop in the stock price of its Indian unit, AstraZeneca Pharma India Ltd. AstraZeneca shares, which have the second biggest weighting in the FTSE 100 index, were down 0.3% at 0820 GMT.



Putin Urges Iran to Take 'Zero Enrichment' Nuclear Deal with US, Axios Reports

Russian President Vladimir Putin attends a meeting with Belgorod region governor Vyacheslav Gladkov in Moscow, Russia July 11, 2025. Sputnik/Mikhail Metzel/Pool via REUTERS/File Photo
Russian President Vladimir Putin attends a meeting with Belgorod region governor Vyacheslav Gladkov in Moscow, Russia July 11, 2025. Sputnik/Mikhail Metzel/Pool via REUTERS/File Photo
TT
20

Putin Urges Iran to Take 'Zero Enrichment' Nuclear Deal with US, Axios Reports

Russian President Vladimir Putin attends a meeting with Belgorod region governor Vyacheslav Gladkov in Moscow, Russia July 11, 2025. Sputnik/Mikhail Metzel/Pool via REUTERS/File Photo
Russian President Vladimir Putin attends a meeting with Belgorod region governor Vyacheslav Gladkov in Moscow, Russia July 11, 2025. Sputnik/Mikhail Metzel/Pool via REUTERS/File Photo

Russian President Vladimir Putin has told US President Donald Trump and Iranian officials that he supports the idea of a nuclear deal in which Iran is unable to enrich uranium, Axios reported on Saturday, citing sources, Reuters reported.

Iran's semi-official news agency Tasnim denied the report, quoting an "informed source" as saying Putin had not sent any message to Iran in this regard.